Acasti Pharma Stock Price - ACST

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Acasti Pharma Inc ACST NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.14 -6.42% 2.04 2.20 1.99 2.18 2.18 16:00:02
Bid Price Ask Price Spread Spread % News
2.00 2.06 0.06 2.91% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,627 1,467,942 $ 2.07 $ 3,032,090 893,152 0.6012 - 2.95
Last Trade Time Type Quantity Stock Price Currency
16:00:00 100 $ 2.04 USD

Acasti Pharma Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 170.48M 84.82M $ -21.50M -0.71 - 85.19M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Acasti Pharma News

Loading Messages....

Latest ACST Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ACST Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week2.182.231.992.1712622k-0.14-6.42%
1 Month2.182.231.772.0171688k-0.14-6.42%
3 Months2.092.951.542.18362M-0.05-2.39%
6 Months0.93192.950.76451.88691M1.1081118.91%
1 Year1.22.950.60121.6448931k0.8470.00%
3 Years1.653.35650.43331.5459537k0.3923.64%
5 Years5.396.20.31351.7403357k-3.35-62.15%

Acasti Pharma Description

Acasti Pharma Inc is a biopharmaceutical company operating in Canada. It focuses on the research, development, and commercialization of prescription drugs using omega-3 fatty acids derived from krill oil. The key product candidate of the company, CaPre is developed for the treatment of severe hypertriglyceridemia, which is a condition characterized by abnormally high levels of triglycerides in the bloodstream. Its only operating segment being the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases.

Your Recent History
Acasti Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.